FDA Places Clinical Hold on Sickle Cell Gene Therapy FDA Places Clinical Hold on Sickle Cell Gene Therapy
FDA placed a clinical hold on two gene therapy clinical trials for sickle cell disease after two patients developed blood diseases.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Clinical Trials | Gene Therapy | Genetics | Hematology | Sickle Cell Anemia